openPR Logo
Press release

Antibacterial Drugs Market: Regional & Competitive Analysis

09-15-2017 02:04 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Antibacterial Drugs Market: Regional & Competitive Analysis

The global antibacterial drugs market, according to TMR, could expand at a CAGR of 1.30% between 2015 and 2023 to achieve a revenue valuation of nearly US$38.9 bn by the final forecast year. Although β-lactams had dominated the market in the past with a larger share, the drug class could lose its share to miscellaneous antibacterials, which are projected to rise at a higher growth rate during the forecast period. Apart from leading the market currently, Asia Pacific could showcase its supremacy by growing at a faster pace in the coming years.

View Full Report: http://www.transparencymarketresearch.com/antibacterial-drugs-market.html

High Prevalence of Infectious Diseases Promises Rewarding Demand

The authors of the report have analyzed the world antibacterial drugs market to garner a handsome demand on the back of the trend of product differentiation ensured using different methods. There could be more factors propelling the demand for antibacterial drugs, such as rising research and development activities, government support, and significant occurrence of infectious diseases. The elevating count of multidrug resistant bacterial strains, surging demand for economical and efficient antibacterial drugs, and swelling geriatric population size could also contribute to the growth of the market. Furthermore, the advancement of novel treatments or innovative molecules has been foreseen to up the growth rate of the market.

Request to view Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1567

Developing markets for antibacterial drugs such as Asia Pacific could offer growth prospects while gaining support from several favorable factors. Improving healthcare infrastructure, enlarging purchasing power of domestic consumers, and the presence of a tall count of manufacturers dealing with generic drugs and active pharmaceutical ingredients (APIs) could help to further the demand in the region.

Request to download and view full ToC: http://www.transparencymarketresearch.com/report-toc/1567

Upcoming Drug Patent Expirations and Influx of Generics Arrest Growth

Players operating in the international antibacterial drugs market are envisaged to witness a setback in demand due to certain reasons such as approaching patent expirations, launch of generic drugs, and increase in drug-resistant bacterial species. Moreover, increased market maturity could pull back the growth of the market.

However, the international antibacterial drugs market could find lucrative opportunities taking over while riding on a smaller number of side effects, reduced onset of action, and emergence of innovative compounds with enhanced efficacy. The implementation of combination products, monoclonal antibodies (mAbs), and new formulations have been forecasted to create more prospects in the market. With only a handful of drugs patented in the market, players could seize the opportunity to introduce new drugs and make their presence known in the industry.

Global Antibacterial Drugs Market Report is available @ US$ 5795

A global antibacterial drugs market intelligence report penned by Transparency Market Research (TMR) has profiled important companies involved in marketing, production, and development activities. As per the analysis of the market’s competitive landscape presented in the report, Pfizer, Inc. could be one of the most promising companies for antibacterial drugs. Besides patients and physicians, the company has been anticipated to widen its customer base with support from private clinics and hospitals as well.

Other players that could make the cut in the global antibacterial drugs market could be Eli Lilly and Company, Bristol-Myers Squibb Company, Bayer AG, and AstraZeneca plc. They have been predicted to participate in constant market competitions and secure a global presence in the pharmaceutical sector.

About Us:
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antibacterial Drugs Market: Regional & Competitive Analysis here

News-ID: 720320 • Views: 159

More Releases from TMR - Research Reports

Visualization and 3D Rendering Software Market: On-Premise Deployment Presently …
The global market for visualization and 3D rendering features a largely consolidated vendor landscape, with the leading three vendors accounting for a nearly 80% of the overall revenue generated in the market in 2016, observes Transparency Market Research in a recent report. These three vendors, namely Autodesk Inc., Dassault Systems, and NVIDIA Corporation, have strengthened their positions in the market with the help of cost competitive pricing, continuous introduction of
Digital Door Lock Systems Market: Enhanced Security Requirements to Propel the D …
According to a new market report published by Transparency Market Research titled “Digital Door Lock Systems Market–Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026,” the global digital door lock systems market was valued at US$ 1,059.5 Mn in 2017 and is expected to expand at a CAGR of 30.25% from 2018 to 2026, reaching US$ 14,877.6 Mn by the end of the forecast period. digital door lock systems market
Transportation Management System Market: Advance Technologies in All the Sectors …
A transportation management system (TMS) refers to a subset of supply chain management and is centered mostly on logistics and transportation. The augmented use of cloud computing technologies for managing supply chain activities is one of the significant and major trends that have been prevailing in the world market for transportation management systems. Cloud-based deployments, in general, need less configuration and customization. These two factors are triggering down the cost
Energy Recovery Ventilators Market: Rising Awareness of Importance of Indoor Air …
Characterized by the presence of a handful of dominant players, namely United Technologies Corp., LG Electronics, Daikin Industries Ltd., Fujitsu Ltd., and Munters Corp., the global energy recovery ventilators market features intense competition, reveals Transparency Market Research (TMR) in a new report. Going forward, the rising number of players seeking entry will further intensify competition in the market. Expansion of product portfolio which has been the focus of established companies to

All 5 Releases


More Releases for Drug

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning